Navigation Links
YM BioSciences third quarter 2010 operational and financial results
Date:5/13/2010

MISSISSAUGA, ON, May 13 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, TSX:YM), today reported operational and financial results for the third quarter of fiscal 2010, ended March 31, 2010.

"During the third quarter, we completed the merging into YM of Cytopia Limited, now YM BioSciences Australia, expanding our pipeline through the addition of two promising new drug candidates in drug classes that have been established as being of high interest and value to the pharmaceutical industry," said David Allan, Chairman and CEO of YM BioSciences. "With a strengthened balance sheet from our recent financing and a portfolio of four late-stage products, the quality and prospects for our drug portfolio are unmatched in YM's history as a company. This quarter we gathered momentum in for our clinical programs with an expansion of our Phase I/II clinical trial for CYT387 as well as the acceptance and presentation of our data at several international forums. We look forward to numerous clinical and corporate events during the balance of 2010."

Highlights for the third quarter of Fiscal 2010:

    -   Merged Cytopia (now YM BioSciences Australia), a clinical-stage, drug
        development company based in Melbourne, Australia, into YM.

    -   Cleared by the US FDA to enroll patients at US clinical sites into
        two ongoing randomized, double-blind Phase II trials of our lead
        product, nimotuzumab.

    -   Expanded the current Phase I/II clinical trial in myelofibrosis
        through an earlier-than-planned initiation of the Phase II component
        of the study for CYT387, the company's highly selective and potent
        JAK1/2 inhibitor.

    -   Had two posters accepted for presentation at the American Association
        for Cancer Resear
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
2. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
3. YM BioSciences announces controlled equity offering
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
5. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
9. YM BioSciences closes US$17.5 million financing
10. YM BioSciences to raise approximately US$15 million
11. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 GEA Niro Soavi ... top laboratory homogenizer, the PandaPLUS 2000, which is ideal ... , and cell disruption . This compact laboratory ... fruit juices, liquid food, food additives and ingredients as ...
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
(Date:1/22/2015)... CAMBRIDGE, Mass. , Jan. 22, 2015   GenoSpace , ... suite of tools to enable the broad use of genomic, ... today announced the appointment of Michelle Munson , CEO ... independent director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2
... , ... Group is pleased to announce that Dr. Michael Langley is joining the company as ... served many roles during his career with Lilly in both animal science and human ... led a number of successful regulatory engagements including both European and US regulatory submissions. ...
... , WINSTON-SALEM, N.C. , Jan. 29 ... They are the stars of a new animated film, "Cell Side ... in cooperation with Wake Forest University and other community ... and female animated characters that dramatize what happens within cells. ...
... Jan. 28 Tissue Genesis, Inc., an emerging leader ... Medical Systems Holdings, Inc. (Nasdaq: AMMD ) announced today ... of adipose (fat)–derived regenerative cells for use in treating pelvic ... over the life of the agreement to obtain rights ...
Cached Biology Technology:Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant 2New Musical 'Cell Side Story' Puts Science on Stage 2New Musical 'Cell Side Story' Puts Science on Stage 3American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 2American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 3American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal 4
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... systems. Multimodal biometric systems utilize more than one characteristic ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a new ... this $50 million capital project is part of a larger ... The medical education building will be located in ... to 525@vine in Wake Forest Innovation Quarter. Construction will begin ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... the American Society of Tropical Medicine and Hygiene, the ... on research advances in the fight against diseases that ... in Central Florida, animal-borne diseases the world over and ... innovations to combat the global epidemic of counterfeit malaria ...
... developed a strain of the Middle East respiratory syndrome coronavirus ... disease, according to a study to be published in ... for Microbiology. The mutant MERS virus, rMERS-CoV-ΔE, has a mutation ... a cell and replicating its genetic material, but deprives it ...
... , Sept. 9, 2013 /PRNewswire-iReach/ -- BioForce Nanosciences, Inc. ... international network of partners and distributors. The partnership will help ... Europe , the Middle East ... Asia . BioForce specializes in nanometer-scale ...
Cached Biology News:American Society of Tropical Medicine and Hygiene 62nd Annual Meeting Nov. 13-17, Washington DC 2American Society of Tropical Medicine and Hygiene 62nd Annual Meeting Nov. 13-17, Washington DC 3Scientists engineer strain of MERS coronavirus for use in a vaccine 2Scientists engineer strain of MERS coronavirus for use in a vaccine 3BioForce Nanosciences, Inc. Expands Its Global Market. New partnership with Acugenex Limited 2
... 1,4-Dithiothreitol DTT ... Purity: ≥99% by titration. ... (100 mM, 1 cm, 260 nm): ≤0.500; ... Heavy metals: ≤0.001%. Soluble ...
... Basically, most ``special`` dye stains are ... few other non-routine) stains are $9.00. ... a paraffin block, staining, coverslipping and ... (for senile plaques) ,Bodian`s Stain ,Copper ...
... Dithiothreitol DTT White solid.. PACKAGED ... to thiols, so reaction is "driven" to completion. ... contain waxy surfactant found in many other preparations. ... Purity: ≥97% by titration. Contaminants: ...
... This kit is designed for easy ... The protocol allows for successful transformation simply ... kit reagents with cultured yeast cells. No ... washing, are required. The kit is particularly ...
Biology Products: